Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Other Non-Current Assets for 17 years, with the latest figure at $4.6 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 388.72% year-over-year to $4.6 million in Q2 2026; TTM through Jun 2026 was $4.6 million, a 388.72% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 141.32% from the prior year.
• Other Non-Current Assets was $4.6 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $4.3 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $4.6 million in Q2 2026, with the low at $264000.0 in Q4 2022.
• Average Other Non-Current Assets over 5 years is $1.2 million, with a median of $951000.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets sank 30.34% in 2022, then surged 388.72% in 2026.
• Over 5 years, Other Non-Current Assets stood at $264000.0 in 2022, then jumped by 327.65% to $1.1 million in 2023, then fell by 15.77% to $951000.0 in 2024, then jumped by 141.32% to $2.3 million in 2025, then soared by 98.26% to $4.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $4.6 million (Q2 2026), $4.3 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.